Search Results - emily+heikamp

1 Results Sort By:
Inhibition of SGK-1 as a Novel Means to Treat Autoimmune Disease and Enhance Anti-pathogen and Anti-tumor Immunity
C11550: Novel Target for Treatment of Autoimmune DiseasesNovelty: Inhibition of this novel target has the potential to treat autoimmune diseases, as well as enhancing immunity against pathogen infections and tumor formation.Value Proposition: Currently, most immunosuppressive therapies non-specifically inhibit the immune system and leave the body susceptible...
Published: 9/26/2024   |   Inventor(s): Emily Heikamp, Jonathan Powell
Keywords(s): Autoimmune Diseases, Biomarker, Cancers, Disease Indication, Immunotherapy, Inflammatory Disorders, Mechanism-of-action Biomarker, Single, Target, Therapeutic Matter, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Immunology
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum